ALPHARISE Trademark

Trademark Overview


On Friday, November 29, 2024, a trademark application was filed for ALPHARISE with the United States Patent and Trademark Office. The USPTO has given the ALPHARISE trademark a serial number of 98878631. The federal status of this trademark filing is NON-FINAL ACTION - MAILED as of Thursday, May 22, 2025. This trademark is owned by Admin Advantage Javea sl. The ALPHARISE trademark is filed in the Pharmaceutical Products category with the following description:

Dietary and nutritional supplements
alpharise

General Information


Serial Number98878631
Word MarkALPHARISE
Filing DateFriday, November 29, 2024
Status641 - NON-FINAL ACTION - MAILED
Status DateThursday, May 22, 2025
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateNOT AVAILABLE

Trademark Statements


Goods and ServicesDietary and nutritional supplements

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateFriday, November 29, 2024
Primary Code005
First Use Anywhere DateFriday, November 29, 2024
First Use In Commerce DateFriday, November 29, 2024

Trademark Owner History


Party NameAdmin Advantage Javea sl
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressJavea 03730
ES

Trademark Events


Event DateEvent Description
Saturday, November 30, 2024NEW APPLICATION ENTERED
Saturday, November 30, 2024NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Saturday, May 17, 2025ASSIGNED TO EXAMINER
Thursday, May 22, 2025NOTIFICATION OF NON-FINAL ACTION E-MAILED
Thursday, May 22, 2025NON-FINAL ACTION E-MAILED
Thursday, May 22, 2025NON-FINAL ACTION WRITTEN